Breast Cancer: Is the ER (estrogen receptor) something genetic or is it variable based on medication (ie. chemotherapy)?
- 1 people answered
Edit Tags
Tags are used to find the best answers
You might also be interested in
Tamoxifen is a highly effective endocrine treatment for breast cancer in the adjuvant and metastatic settings. Data from several large randomized clinical trials indicate that tamoxifen is also valuable in the prevention of breast cancer in women at high risk for the disease. However, not all women ....
You cannot be sure if you have breast cancer just by detecting a lump in the breast. A biopsy is necessary to identify if a lump is cancerous or not. For this, you have to visit a specialist who will examine your breasts and ask for some diagnostic tests.Though, at home, to identify any lumps, you c....
The thought of breast cancer can send shivers down your spine. It is a rather common form of cancer, which can lead to many complications and adverse effects. Moreover, it can affect women at any age, and sometimes it can affect teens. There are no definite causes of breast cancer in teens. However....
Credihealth is not a medical practitioner and does not provide medical advice. You should consult your doctor or with a healthcare professional before starting any diet, exercise, supplementation or medication program. Know More
লেখা:Dr. Nitika Sharma - BDS
পর্যালোচনা করা হয়েছে:Dr. Rakesh Kumar - MBBS, MS
Mahima Chaudhary
Receptors are proteins in or on cells that can attach to certain substances in the blood. Normal breast cells and some breast cancer cells have receptors that attach to the hormones estrogen and progesterone, and depend on these hormones to grow.
The breast tissue estrogen receptor is both genetic and variable in the presence of chemotherapy and other medications.
Breast cancer cells may have one, both, or none of these receptors.
ER-positive: Breast cancers that have estrogen receptors are called ER-positive (or ER+) cancers.
PR-positive: Breast cancers with progesterone receptors are called PR-positive (or PR+) cancers.
Keeping these receptors from attaching to the hormones can help keep the cancer from growing and spreading. There are drugs that can be used to do this.
Knowing the hormone receptor status of your cancer helps doctors decide how to treat it. If your cancer has one or both of these hormone receptors, hormone therapy drugs can be used to either lower estrogen levels or stop estrogen from acting on breast cancer cells. This kind of treatment is helpful for hormone receptor-positive breast cancers, but it doesn’t work on tumors that are hormone receptor-negative (both ER- and PR-negative).